Clinical assessment of recovery from neuromuscular blockers, is it a safe practise - An observational study

Author:

Shaji Govind1ORCID,Mishra Gayatri1ORCID

Affiliation:

1. Mahatma Gandhi Medical College and Research Institute, Pillaiyarkuppam, Pondicherry, India

Abstract

The incidence of residual neuromuscular paralysis (RNMB) with Train of four ratio<0.9 remains as high as 16% in PACU even after administration of reversal when neuromuscular monitoring is not done. Reversal with standard dose of neostigmine and extubation are done based on the clinical signs. We observed the clinical signs of neuromuscular recovery and correlated with neuromuscular monitoring to assess the degree of residual blockade in the post-operative period.100 Patients posted for surgery under general anaesthesia with endotracheal tube intubation and controlled ventilation were enrolled for the study after obtaining human ethical approval. Standard anaesthesia technique using morphine, propofol, vecuronium, isoflurane with low flow anaesthesia were administered for all patients. TOF was noted at the end of surgical procedure when patient resumed spontaneous respiration, during extubation, and at 15 minutes interval for one hour in the postoperative period. Hemodynamics were observed including respiratory rate. Overall 32 percent of patients had residual paralysis. 27% at 15 min, 26% at 30min, 6% at 45min and 3% at one hour in the postoperative period showed RNMB. Subgroup analysis showed that at the time administration of reversal 72 patients had (TOFR>0.4) and 28 had (TOFR<.0.4), showed significant difference in improvement in TOFR between 2 subgroups before reversal, immediate extubation and 15 min post extubation (p=0.00,0.001,0.003,) respectively. Clinical findings of neuromuscular reversal is not foolproof for complete recovery and standard dose neostigmine given during shallow block will accentuate the residual neuromuscular paralysis.

Publisher

IP Innovative Publication Pvt Ltd

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3